Search clinical trials for: Antiretroviral therapy plus Interleukin-2

Total 1778 results

Juan A. Arnaiz

Completed

Intermittent ART in Primary HIV Infection (PHI-IL2)

HIV

Spain
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
Providence Health & Services
Prometheus Laboratories

Active, not recruiting

Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

Metastatic Melanoma

United States
Luis Espejo Antúnez PhD

Completed

Effects of Electric Massage on the Cervical Region in Subjects Diagnosed With Temporomandibular Disorders

Temporomandibular Disorders

Spain
Universidad Rey Juan Carlos

Unknown

Assessment Effectiveness of the Leap Motion Capture® System on the Functionality of the Upper Limb in Acquired Brain Injury

Stroke | Brain Injuries, Traumatic | Treatment Adherence | Patient Satisfaction

Spain
Assistance Publique - Hôpitaux de Paris

Completed

Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes (DFIL2-Child)

Type 1 Diabetes

France
University of Valencia

Completed

Manual Therapy, Thera-band Exercise and Walking (MTBEW)

Aging

Spain
Colorado State University
American Occupational Therapy Foundation

Unknown

Education and Exercise Program for Adults With Type 2 Diabetes

Type 2 Diabetes

United States
University Hospital, Bordeaux

Completed

Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment (ANEMIL)

Autoimmune Hemolytic Anemia

France
Myrexis Inc.

Terminated

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

HIV Infections

Canada, United States
St. Jude Children's Research Hospital
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma

Neuroblastoma

United States
University of Michigan Rogel Cancer Center
University of Michigan

Terminated

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Metastatic Colorectal Cancer

United States
Loma Linda University

Withdrawn

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Melanoma | Metastatic Kidney Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

HIV Infections
Saint John's Cancer Institute
Melanoma Research Alliance

Terminated

Stage IV Surgery Versus Best Medical Therapy (STG4SURG)

Stage IV Resectable Melanoma

United States, Australia, Israel, Italy, Netherlands
Weill Medical College of Cornell University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I

Hepatitis C

United States
Beijing YouAn Hospital
China Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine and other collaborators

Unknown

A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease

Hand, Foot and Mouth Disease

China
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low-dose Interleukin-2 in Women With Unexplained Miscarriages (FaCIL-2)

Recurrent Miscarriage

France
Johns Hopkins University

Withdrawn

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

Aphasia

United States
Parc de Salut Mar

Completed

Self-screening of Cardiovascular Risk (ACRISC)

Risk Factor, Cardiovascular

Spain
Centers for Disease Control and Prevention
The AIDS Support Organization; British Medical Research Council

Completed

Comparison of Facility and Home-based ART Delivery Systems in Uganda

AIDS

Uganda
Rockefeller University
Aaron Diamond AIDS Research Center

Completed

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

HIV Infections

United States
City of Hope Medical Center

Completed

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

Glioblastoma | Brain Tumor | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Giant Cell Glioblastoma | Anaplastic Meningioma | Mixed Glioma | Brain Stem Glioma | Ependymoblastoma | Grade III Meningioma | Meningeal Hemangiopericytoma | Pineal Gland Astrocytoma

United States
University of Maryland, Baltimore

Withdrawn

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

Breast Cancer With Brain Metastasis

United States
University of Palermo

Completed

Effectiveness of Physical Therapy for Pain Relief in Footballers With Muscle Injuries: a Prospective Study

Athletic Injuries | Physical Therapies

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Ultra Low Dose Interleukin-2 in Healthy Volunteers

Hematologic Diseases

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation (RAFT-PermAF)

Atrial Fibrillation | Heart Disease | Congestive Heart Failure

Canada
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR); Medtronic

Completed

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT)

Heart Failure, Congestive

Canada, Netherlands, Australia, Turkey, Denmark, Germany, Belgium
Auxilium Vitae Volterra

Completed

Transcranial Direct Current Stimulation and Robotic Therapy in Upper Limb Motor Recovery After Stroke

Stroke

Italy
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

HIV Infections

France
National Center for Research Resources (NCRR)
Elizabeth Glaser Pediatric AIDS Foundation

Completed

The Metabolic Effects of Protease Inhibitors in HIV Infected Children

HIV Infections

United States
University of West Attica

Recruiting

Manual Therapy to the Cervical Spine and Diaphragm Combined With Breathing Reeducation Exercises, in nsCNP Patients

Chronic Neck Pain

Greece
National Cancer Institute (NCI)

Terminated

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Recurrent Neuroblastoma

United States
Johns Hopkins University

Active, not recruiting

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

Primary Progressive Aphasia

United States
Icahn School of Medicine at Mount Sinai

Completed

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

Common Variable Immunodeficiency
Aalborg University Hospital

Unknown

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 (HEPVACHIV)

HIV Infections | Hepatitis B | Hepatitis A

Denmark
Astellas Pharma Global Development, Inc.

Completed

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer (PILOT)

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric Adenocarcinoma

Germany, Latvia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Peking University Cancer Hospital & Institute

Completed

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion (GMPE)

Breast Neoplasms | Neoplasm Metastasis | Immunotherapy | Gene Expression Profiling

China
Hospices Civils de Lyon

Completed

Impact of CMV Status on HIV Viral Load Decay

Hiv

France
King's College London
King's College Hospital NHS Trust

Terminated

Low-dose IL-2 for Treg Expansion and Tolerance (LITE) (LITE)

Liver Diseases | Transplantation

United Kingdom
Yantai Yuhuangding Hospital

Recruiting

Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

Alcoholic Cirrhosis

China
University Hospital, Tours
Swedish Orphan Biovitrum; INSERM CIC-P 1415, University Hospital Center of...

Terminated

Anakinra for COVID-19 Respiratory Symptoms (ANACONDA)

COVID-19 Infection | ANAKINRA Treatment | Optimized Standard of Care (oSOC)

France
Johns Hopkins University
National Institutes of Health (NIH); National Institute on Deafness and Other...

Completed

tDCS Intervention in Primary Progressive Aphasia

Primary Progressive Aphasia | MCI | FTD

United States
Vical
National Cancer Institute (NCI); Jonsson Comprehensive Cancer Center

Terminated

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

United States
University of Washington
National Institute of Mental Health (NIMH)

Recruiting

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV (HeadStART)

HIV Infections | Hiv

Uganda
Peking Union Medical College Hospital

Completed

Gut Microbiota Changes of HIV Patients Before and After One Year of ART

HIV Infections

China

Search clinical trials for: Antiretroviral therapy plus Interleukin-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations